Abstract
OA02.04 Phase 1/2 Randomized Trial of Anetumab Ravtansine and Pembrolizumab Compared to Pembrolizumab for Pleural Mesothelioma - NCT03126630
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have